Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
1170.50
Change Change %
-13.80 -1.17%

Updated:18 Jul, 2019, 15:56 PM IST

BSE
1169.60
Change Change %
-13.45 -1.14%

Updated:18 Jul, 2019, 16:01 PM IST

Glaxosmithkline Phar's Financial Summary

View last 5 years Financial Summary

Parameter MAR'19 MAR'18
Operational & Financial Ratios:
   Earnings Per Share (Rs) 25.11 41.56
   DPS(Rs) 20.00 35.00
   Book NAV/Share(Rs) 126.47 245.56
Margin Ratios:
   Yield on Advances 0.00 0.00
   Yield on Investments 0.00 0.00
   Cost of Liabilities 0.00 0.00
   NIM 0.00 0.00
   Interest Spread 0.00 0.00
Performance Ratios:
   ROA(%) 5.53 4.98
   ROE(%) 20.15 17.14
   ROCE(%) 31.45 26.36
Efficiency Ratios:
   Cost Income Ratio 0.00 0.00
   Core Cost Income Ratio 0.00 0.00
   Operating Costs to Assets 0.00 0.00
Capitalisation Ratios:
   Tier 1 ratio 0.00 0.00
   Tier 2 ratio 0.00 0.00
   CAR 0.00 0.00
Valuation Parameters:
   PER(x) 51.77 25.09
   PCE(x) 46.46 45.30
   Price / Book(x) 10.28 8.49
   Yield(%) 1.54 1.68
   EV / Net Sales(x) 6.67 5.71
   EV / Core EBITDA(x) 29.47 29.16
   EV / EBIT(x) 31.41 30.24
   EV / CE(x) 2.68 2.16
   M Cap / Sales 7.04 6.15
Growth Ratio:
   Core Operating Income Growth 193.13 -24.36
   Operating Profit Growth 25.98 14.23
   Net Profit Growth 20.85 4.52
   BVPS Growth -48.50 2.55
   Advances Growth 0.00 0.00
   EPS Growth(%) -39.58 4.52
Liquidity Ratios:
   Loans / Deposits(x) 0.00 0.00
   Total Debt / Equity(x) 0.00 0.00
   Current Ratio(x) 0.00 0.00
   Quick Ratio(x) 0.00 0.00
   Total Debt / Mcap(x) 0.00 0.00
   Net NPA in Rs. Million 0.00 0.00
Top